Autres langues RedHill Biopharma Ltd. TEL AVIV STOCK EXCHANGE

Actions

RDHL

IL0011223810

Temps Différé TEL AVIV STOCK EXCHANGE Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^ILa	-.--%		-9,57%	-17,72%

06/05	Redhill Biopharma obtient un brevet en Chine pour l'opaganib, un médicament expérimental contre le virus Ebola	MT
06/05	RedHill Biopharma Ltd. annonce la délivrance d'un nouveau brevet chinois sur l'opaganib contre le virus Ebola, valable jusqu'en 2035	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib	06/05
RedHill Biopharma : Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 - Form 6-K	06/05
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035	06/05
RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035	06/05
RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K	24/04
RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study	24/04
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights	09/04
RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	08/04
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price	03/04
RedHill Biopharma Ltd. cancelled the transaction announced on March 8, 2023	28/03
Redhill Biopharma Says Talicia Gets New US Patent to Treat Helicobacter Pylori Infection	11/03
RedHill Biopharma : Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs - Form 6-K	05/03
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs	05/03
U.S. government Selects RedHill Biopharma Ltd.'s Opaganib for Evaluation by BARDA and NIH Countermeasures Programs	05/03
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis, New Publication	21/02
Redhill Biopharma Ltd. Announces New Publication of Data from Multiple Experiments in the International Journal of Molecular Sciences	20/02
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication	20/02
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL	31/01
Redhill Biopharma Closes $8 Million Registered Direct Offering of American Depositary Shares	26/01
RedHill Biopharma Announces $8 Million Registered Direct Offering	26/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues RedHill Biopharma Ltd. TEL AVIV STOCK EXCHANGE

Actions

RDHL

IL0011223810

Autres langues

Filtres